Proud Sponsor of APHCA’s Annual Conference
RxStrategies is a proud Platinum Presenting Sponsor of Alabama Primary Health Care Association’s (APHCA) 33rd Annual Conference and Trade Show. October 2-4 in Orange Beach, AL, members, partners and collaborators will join together to network and gain insight into leadership, management and compliance strategies. Visit booth #1 at the conference to discuss intuitive 340B solutions with…
Intuitive Contract Pharmacy Management through Advanced Reporting and Analytics
RxStrategies emphasizes a conservative approach to 340B contract pharmacy administration while maximizing program results. Our simple, all-inclusive fee ensures more of the 340B savings remain with the Covered Entity (CE). In addition, our audit-proven eligibility matching algorithm drives matches to qualify each individual transaction. Our 340B Contract Pharmacy Solution: Intuitive, Cloud-Based Platform: Provides unprecedented insights into…
Schedule Your 340B Demos Now!
The 2018 340B Coalition Summer Conference is just around the corner. July 9-11, we will be in Washington, D.C. as a Pinnacle Leader Sponsor for the conference, ready to connect with you and gain insight into the latest news and trends concerning the 340B Drug Discount Program. If you are attending, be sure to schedule…
Comprehensive Solutions for Your FQHC
According to NACHC, “community health centers serve as the primary medical home for more than 27 million people in 10,400 rural and urban communities across America.” Just one form of Federally Qualified Health Centers (FQHC), community health centers receive funds from the HRSA Health Center Program to support and serve underserved areas (HRSA). The number…
Clinical Insights: May 1, 2018
Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. New Drug Approval JynarqueTM (tolvaptan) – April 24, 2018 – Otsuka Pharmaceutical Co., Ltd. (Otsuka) announces that the U.S. Food and Drug Administration (FDA) has approved JynarqueTM (tolvaptan) as…
Connect with Us at the CPS Annual Meeting & Vendor Expo
May 2-4, Vice President – Implementations and Sales Support Ryen Brumbeloe and Sales Manager – Midwest Region Todd Hudnall will attend and exhibit at the Comprehensive Pharmacy Systems/Pharmacy Systems, Inc. (CPS) Annual Meeting & Vendor Expo in Indianapolis, IN. There, over 450 pharmacy decision makers will connect and gain insight into the latest industry news….
Stay on Top of 340B with Split Billing
RxStrategies recognizes the complexities of 340B program management and offers solutions to better ensure proper management and program compliance. With our Split Billing Solution, you can: Review prescription activity Flag eligible 340B dispenses Designate activity for proper replenishment Audit and report GPO, WAC and 340B With customized reporting, onsite audit support, order confirmations, pharmacy system…
Make Your Appointment Now!
The 340B Coalition Winter Conference in San Diego, California is coming up in exactly two weeks! Don’t forget to make your appointment with our team at RxStrategies to discuss solutions to support program compliance and view our 340B CompliancePlus Demo or Dashboard Analytics Demo. Schedule a demo for the conference » Visit Booth #227/326 at…
Get Ready for the 340B Coalition Winter Conference
The 340B Coalition Winter Conference this year takes place during the 25th year of the 340B Program. On February 21-23 in San Diego, California, industry leaders will meet to discuss the latest issues in the program, from regulations and legislative activity to drug prices and government studies. Be sure to stop by Booth #227/326 at…
Clinical Insights: January 22, 2018
Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. New Drug Approval BalcoltraTM (levonorgestrel and ethinyl estradiol and ferrous bisglycinate) – January 19, 2018 – Avion Pharmaceuticals, LLC, received approval of its new drug application (NDA) for the oral contraceptive…
Join Us at the 340B Coalition Winter Conference!
Join the RxStrategies team at the 340B Coalition Winter Conference in San Diego, California February 21-23. Here, your team can stay up to date on the latest news, trends and regulations in the 340B program to best maintain compliance. We look forward to connecting with industry leaders while gaining insight on 340B happenings and issues…
Maintain 340B Program Compliance in 2018
RxStrategies works with Covered Entities to provide an integrated approach to streamline the delivery of quality care, while maximizing savings and meeting the regulatory challenges associated with 340B program management. RxStrategies’ 340B solutions are key to a comprehensive and compliant 340B program. RxStrategies’ CompliancePlus Audit Solution (Self-Audit Portal) Implement internal processes, controls and protocols that…
- « Previous
- 1
- 2
- 3
- Next »